SCHEMBL1005303

SCHEMBL1005303

C=C(C)C(=O)OCc1cc(C)cc(N=Nc2cc(OC)c(OC)c(OC)c2)c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.36
▸ GFER P55789 1/20 0.35
▸ KMT2A Q03164 5/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ ERN1 O75460 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ SCN2A Q99250 1/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005301 1.00 ACHE (0.36) ACHEGFERKMT2AMEN1MAPT
SCHEMBL825301 0.85 MAPT (0.49) ACHEKMT2AMEN1MAPTL3MBTL1
SCHEMBL825302 0.85 MAPT (0.49) ACHEKMT2AMEN1MAPTL3MBTL1
SCHEMBL29883561 0.85 MAPT (0.49) ACHEKMT2AMEN1MAPTL3MBTL1
SCHEMBL12107154 0.84 THRB (0.41) ACHEKMT2AMEN1MAPTL3MBTL1
SCHEMBL2589702 0.84 THRB (0.41) ACHEKMT2AMEN1MAPTL3MBTL1
SCHEMBL10001947 0.82 THRB (0.31) —
SCHEMBL10001950 0.81 THRB (0.36) KMT2AMEN1MAPTL3MBTL1NPC1
SCHEMBL1005125 0.79 GFER (0.46) ACHEGFERKMT2AMEN1MAPT
SCHEMBL1005126 0.79 GFER (0.46) ACHEGFERKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2564245-B1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES ALCON INC (CH) 2021-01-27 — — EP claimed
EP-2451875-B1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2013-08-28 — — EP claimed
EP-2564245-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES Novartis AG (CH) 2013-03-06 — — EP claimed
US-8262948-B2 Intraocular lenses with combinations of UV absorbers and blue light chromophores NOVARTIS AG (CH) 2012-09-11 — — US claimed
US-8207244-B2 Visible light absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2012-06-26 — — US claimed
EP-2451875-A2 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS Novartis AG (CH) 2012-05-16 — — EP claimed
WO-2011137142-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES NOVARTIS AG (CH) 2011-11-03 — — WO claimed
US-20110266505-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES ALCON INC. (CH) 2011-11-03 — — US claimed
WO-2011005713-A2 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-13 — — WO claimed
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-06 — — US claimed
US-8262948-B2 Intraocular lenses with combinations of UV absorbers and blue light chromophores NOVARTIS AG (CH) 2012-09-11 — — US disclosed
US-8207244-B2 Visible light absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2012-06-26 — — US disclosed
US-20110266505-A1 INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES ALCON INC. (CH) 2011-11-03 — — US disclosed
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2011-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003910-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS CRY1, CRY2, CRYAA ACHE 530/4885GFER 32/4885KMT2A 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback